Interested in Connecting? Please contact: Damion Boyer COO firstname.lastname@example.org
Message the company or request a 1:1 meeting here.
Corvidane is using a novel approach to develop one drug capable of addressing the two leading causes of death and the leading cause of liver transplants.
Following early development, Corvidane plans to sell or license Corvida™ within 5 years.